Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

5-Number Summary

5-Number Summary

In a dataset, the 5-number summary includes the minimum data value, the data value of the first quartile, the median data value or data value of the second quartile, the data value of the third quartile, and the maximum data value. These 5 data values can be visualized as a box and whisker plot.
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...

Discharge Summary Forms

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic model.

Health technology assessment (Winchester, England)·2026

Same author

Meta-regression with categorical moderators and dependent effect sizes: A simulation study.

Research synthesis methods·2026

Same author

Reflections on the I-squared index for measuring inconsistency in meta-analysis.

Research synthesis methods·2026

Same author

Smoking cessation for people with severe mental illness: systematic review and network meta-analysis.

BMJ medicine·2026

Same author

Treatment recommendations based on network meta-analysis: Rules for risk-averse decision-makers.

Research synthesis methods·2026

Same author

Synthesis of depression outcomes reported on different scales: A comparison of methods for modelling mean differences.

Research synthesis methods·2026

Search research articles

Related Experiment Video

Updated: Jan 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Shared parameter model for competing risks and different data summaries in meta-analysis: Implications for common and

Howard Thom¹, José A López-López^1,2, Nicky J Welton¹

¹Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.

Research Synthesis Methods

|July 23, 2019

Summary

In aggregate data meta-analysis, a shared parameter model is crucial when dealing with multiple competing risks and varied data summaries. Simpler models suffice only if all absolute event rates remain below 0.2 to prevent biased results.

Keywords:

competing risks different data summaries meta-analysis network meta-analysis rare events shared parameter models

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Related Experiment Videos

Last Updated: Jan 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Area of Science:

Biostatistics
Epidemiology
Medical Research Methodology

Background:

Aggregate data meta-analysis often involves studies with multiple competing binary outcomes.
Studies may report outcomes using different summary formats, complicating data synthesis.

Purpose of the Study:

To develop and evaluate a shared parameter model for meta-analysis with competing risks and diverse data summaries.
To determine the event rate threshold below which simpler models are adequate.

Main Methods:

Development of a shared parameter model on the hazard ratio scale.
Adaptation of theoretical arguments to assess model equivalence.
Utilizing constructed data examples and simulation studies to identify bias thresholds.

Main Results:

Models are equivalent when events are rare.
An event rate threshold of approximately 0.2 was identified.
Above this threshold, competing risks and varied data summaries can bias results without adjustments.

Conclusions:

Analysts should consider absolute event rates in meta-analysis.
A shared parameter model is recommended if event rates approach or exceed 0.2 to avoid biased estimates.
Simpler models are sufficient only when all underlying events are rare (below 0.2).